PFEPfizer
Pfizer Inc. is a research-based, global biopharmaceutical company. 10-K, Item 1
- Employees
- 75,000
- Headquarters
- New York, NY
- CEO
- Albert Bourla
- Next results
- around Feb 2, 2027
Every trade in PFE shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.
Bought on the market
$3.0M
3 trades by 3 insiders
Sold on the market
$135K
2 trades by 1 insider
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourla | Chairman & CEO, Director | Buy | 38,000 | 26.34 | 1.0M | 429,173 |
| Aug 5, 2026 | Mortimer J. Buckley | Director | Buy | 37,632 | 25.52 | 960K | 37,632 |
| Aug 5, 2026 | Ronald E. Blaylock | Director | Buy | 39,231 | 25.46 | 999K | 66,938 |
| Aug 5, 2026 | Jennifer B. Damico | SVP & Controller | Sale | -3,278 | 25.40 | 83K | 28,611 |
| Jun 9, 2026 | Jennifer B. Damico | SVP & Controller | Sale | -2,000 | 25.70 | 51K | 31,397 |
From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).
Work on PFE in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/PFE/export.csv") into a cell.